When was Shenshi Technology founded?

Shenshi Technology was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Shenshi Technology located?

Shenshi Technology is headquartered in Beijing, China.

How many employees does Shenshi Technology have?

As of Aug 31, 2026, the latest employee count at Shenshi Technology is 107.

Is Shenshi Technology a funded company?

Shenshi Technology is a funded company, having raised a total of $255M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 2020.

When was the latest funding round of Shenshi Technology?

Shenshi Technology's latest funding was a $***** Series C round on Dec 24, 2025, with participation from 5 investors.

Where does Shenshi Technology rank among its competitors?

Shenshi Technology ranks 19th amongst 214 active competitors, of which 71 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Isomorphic Labs, which secured $2.1B in May, 2026.

Who are the top competitors of Shenshi Technology?

Shenshi Technology's top competitors include Schrodinger, Recursion Pharmaceuticals and Valo Health. Among them, Isomorphic Labs secured the most recent funding round in May, 2026.

Shenshi Technology - 2026 Company Profile, Funding & Competitors

Company Details

Developer of AI-driven platform and tools for scientific research and development. The platform offers resources for accessing academic literature, managing research projects, and running code. It provides a unified environment connecting software and hardware resources. The platform supports data management, environment replication, and team collaboration. It facilitates structured data analysis for scientific applications across various disciplines.

Website: www.dp.tech
Email ID: *****@dp.tech
Phone Number: +86 **********

Key Metrics

Founded Year

2019

Location

Beijing, China

Stage

Series C

Total Funding

$255M in 8 rounds

Latest Funding Round

Series C, Dec 24, 2025, $*****

Investors

Qiming Venture Partners & 23 more

Ranked

19^th among 214 active competitors

Employee Count

107 as on Aug 31, 2026

Similar Companies

OpenEvidence & 3022 more

View Shenshi Technology's full profile

Shenshi Technology has raised a total funding of $255M over 8 rounds. Its first funding round was on Jul 2020. Its latest funding round was a Series C round on Dec 24, 2025 for $*****. 5 investors participated in its latest round. Shenshi Technology has 24 institutional investors.

Here is the list of recent funding rounds of Shenshi Technology:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 24, 2025	8649023	Series C	9441625	6713277	9772841	8614965
Oct 15, 2024	7548511	Series B	7204582	5056519	2254147	8923230
Aug 19, 2023	5851145	Series B	3816153	2773876	2046550	MSA Capital & 5 more

Access funding benchmarks and valuations. Sign up today!

View details of Shenshi Technology's funding rounds and investors

Shenshi Technology's employee count trend

Shenshi Technology has 107 employees as of Aug 26. Here is Shenshi Technology's employee count trend over the years:

Employee count trend for Shenshi Technology

Uncover Shenshi Technology's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Shenshi Technology include Schrodinger, Recursion Pharmaceuticals and Valo Health. Here is the list of Top 10 competitors of Shenshi Technology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Schrodinger 1990, New York City (United States), Acquired	Provider of a web-based simulation and modelling tool	$162M	Gates, WuXi AppTec & 16 others	74/100
2nd	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	Baillie Gifford, DCVC & 47 others	72/100
3rd	Valo Health 2019, Boston (United States), Series B	AI-powered platform for drug discovery and development	$450M	PSP Investments, Koch Disruptive Technologies ... & 7 others	67/100
4th	XtalPi 2014, Cambridge (United States), Public	AI-based drug research and development company	$785M	SoftBank Vision Fund, Orbimed & 25 others	67/100
5th	Isomorphic Labs 2021, London (United Kingdom), Series B	Digital platform focused on revolutionizing drug discovery using AI	$2.7B	Thrive Capital, CapitalG & 6 others	64/100
6th	Xaira 2023, San Francisco (United States), Series D	AI-enabled platform for drug discovery and development	$1B	Arch Venture Partners, Foresite Labs & 11 others	63/100
7th	In Silico 2014, Cambridge (United States), Public	AI-enabled bioinformatics platform for drug discovery and biomarker development	$510M	Qiming Venture Partners, Prosperity7 Ventures ... & 36 others	62/100
8th	Tandem AI 2021, New York (United States), Series A	AI-based drug discovery tool for researchers	$82M	Orbimed, Chengwei Capital & 4 others	62/100
9th	Causaly 2018, London (United Kingdom), Series B	Provider of an AI platform for life sciences and biomedical research	$93M	Index Ventures, EBRD & 14 others	62/100
10th	Aqemia 2019, Paris (France), Series A	Provider of an AI and quantum physics to discover therapeutic molecules	$101M	Cathay Innovation, Elaia & 4 others	62/100
19th	Shenshi Technology 2019, Beijing (China), Series C	Developer of AI-driven platform and tools for scientific research and development	$255M	MSA Capital, Loayal Valley Capital & 22 others	58/100